MedPath

Clinical Evaluation of Anaesthetic Efficacy of 4% Articaine Buccal Infiltration Versus Inferior Alveolar Nerve Block

Not Applicable
Not yet recruiting
Conditions
Restorative Dental Treatment by Buccal Infiltration Anaesthesia
Interventions
Other: 4% articaine infiltration
Registration Number
NCT06353815
Lead Sponsor
Cairo University
Brief Summary

Clinical evaluation of anaesthetic efficacy of 4% articaine buccal infiltration versus inferior alveolar nerve block during restorative dental treatment in mandibular first permanent molars

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
44
Inclusion Criteria
  • Clinical Criteria:

    • Children aged between 6 years and 9 years having:
    • Mandibular first permanent molar with simple caries not involving pulp showing the following criteria: A. No history of spontaneous pain, pathologic mobility, draining sinus tract, redness or swelling of the vestibule. B. Normal gingival and periodontal condition, with no sensitivity to vestibular palpation, and no pain on percussion test.

Radiographic criteria:

  • No sign of radiolucency in periapical or furcation area.
  • No widening of PDL space or loss of lamina dura continuity.
  • No evidence of internal/external pathologic root resorption
Read More
Exclusion Criteria
  • • Uncooperative children.

    • Children with systemic disease.
    • Lack of informed consent by the child patient's parent.
    • Refusal of participation.
    • Allergy from anesthetic agent.
    • Acute infection
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group II (Control group) 4% articaine inferior alveolar nerve block4% articaine infiltration-
Group I (Experimental group) 4% articaine infiltration4% articaine infiltration-
Primary Outcome Measures
NameTimeMethod
Success of local anesthesia10 minutes

Operator will record the LA as Successful if the scheduled restorative treatment was completed with standard treatment management strategies after administration of the trial anaesthetic. If treatment could not be continued after 10 minutes from when the LA was first administered, and the full 1.8 ml cartridge of the trial anaesthetic had been used, then the LA was considered unsuccessful

Secondary Outcome Measures
NameTimeMethod
Child behavior during treatmentIntraoperative

Doaa Moustafa: he patient's behavior will be evaluated for pain perception during treatment using the SEM scale (Appendix 3: SEM scale ). The SEM scale is an objective pain \[10:04 pm, 31/3/2024\] Doaa Moustafa: assessment scale with scores ranging from 1 to 4, illustrating comfort to severe discomfort based on sounds, eye, motor parameters

© Copyright 2025. All Rights Reserved by MedPath